Ubiquitomics: an overview and future by Vere, G, Kealy, R, Kessler, B, Pinto-Fernandez, A

Targeting the ubiquitylation and ISGylation machinery for the treatment of COVID-19 by Vere, G, Alam, MR, Farrar, S, Kealy, R, Kessler, BM, O’Brien, DP, Pinto-Fernández, A

Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase complex by Damianou, A, Liang, Z, Lassen, F, Vendrell, I, Vere, G, Hester, S, Charles, PD, Pinto-Fernandez, A, Santos, A, Fischer, R, Kessler, BM

Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity by Pinto-Fernandez, A, Salio, M, Partridge, T, Chen, J, Vere, G, Greenwood, H, Olie, CS, Damianou, A, Scott, HC, Pegg, J, Chiarenza, A, Diaz-Saez, L, Smith, P, Gonzalez-Lopez, C, Patel, B, Jones, N, Hammonds, T, Huber, K, Muschel, R, Borrow, P, Cerundolo, V, Kessler, B

USP28 deletion and small molecule inhibition destabilises c-MYC and elicits regression of squamous cell lung carcinoma by Ruiz, EJ, Pinto-Fernandez, A, Turnbull, AP, Lan, L, Charlton, TM, Scott, HC, Damianou, A, Vere, G, Riising, EM, Da Costa, C, Krajewski, WW, Guerin, D, Kearns, JD, Ioannidis, S, Katz, M, McKinnon, C, O'Connell, J, Moncaut, N, Rosewell, I, Nye, E, Jones, N, Heride, C, Gersch, M, Wu, M, Dinsmore, CJ, Hammonds, TR, Kim, S, Komander, D, Urbe, S, Clague, MJ, Kessler, BM, Behrens, A